Rigel (RIGL) CMO uses 850 shares to cover stock tax liability

Rhea-AI Filing Summary

RIGEL PHARMACEUTICALS INC EVP and Chief Medical Officer Lisa Rojkjaer reported a tax-related share disposition. On June 1, 2026, 850 shares of Common Stock were transferred at $29.86 per share to cover an exercise price or tax liability by delivering securities.

After this transaction, she directly owned 34,003 shares of Rigel common stock. The filing reflects a tax-withholding disposition rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rojkjaer Lisa

Role EVP, Chief Medical Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	850	$29.86	$25K

Holdings After Transaction: Common Stock — 34,003 shares (Direct, null)

Footnotes (1)

Key Figures

Shares disposed: 850 shares Transaction price: $29.86 per share Shares owned after: 34,003 shares

3 metrics

Shares disposed 850 shares Tax-withholding disposition on June 1, 2026

Transaction price $29.86 per share Value used for the 850-share disposition

Shares owned after 34,003 shares Direct common stock ownership post-transaction

Key Terms

tax-withholding disposition, Payment of exercise price or tax liability by delivering securities, Common Stock

3 terms

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition" for 850 shares"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Payment of exercise price or tax liability by delivering securities financial

"transaction_code_description explains code F as this payment method"

Common Stock financial

"security_title is listed as "Common Stock" in the transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rojkjaer Lisa

(Last) (First) (Middle)

RIGEL PHARMACEUTICALS, INC.

611 GATEWAY BLVD, SUITE 900

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RIGEL PHARMACEUTICALS INC [ RIGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		F		850	D	$29.86	34,003	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Raymond Furey (Attorney-in-Fact)	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Rigel (RIGL) report for Lisa Rojkjaer?

Rigel reported that EVP and Chief Medical Officer Lisa Rojkjaer transferred 850 shares of common stock in a tax-withholding disposition. This was recorded as a payment of exercise price or tax liability by delivering securities, not as an open-market trade.

How many Rigel (RIGL) shares were involved in Lisa Rojkjaer’s Form 4?

The Form 4 shows 850 shares of Rigel common stock were disposed of in a tax-withholding transaction. The shares were valued at $29.86 per share for this purpose, based on the transaction price disclosed in the filing.

What was the price per share in Lisa Rojkjaer’s Rigel (RIGL) tax-withholding transaction?

The filing lists a transaction price of $29.86 per share for the 850 Rigel common shares used in the tax-withholding disposition. This price is the basis for valuing the shares delivered for tax or exercise obligations.

How many Rigel (RIGL) shares does Lisa Rojkjaer hold after this Form 4 transaction?

After the tax-withholding disposition, Lisa Rojkjaer directly holds 34,003 shares of Rigel common stock. This post-transaction balance reflects her remaining direct ownership as reported in the Form 4 filing’s share balance field.

Was Lisa Rojkjaer’s Rigel (RIGL) Form 4 an open-market sale or purchase?

No, the Form 4 describes a tax-withholding disposition coded as “F,” meaning shares were delivered to satisfy an exercise price or tax liability. It is not classified as an open-market buy or sell transaction in the filing.